文献速递脑血管病外科神经重症

颅内动脉夹层所致脑梗死与蛛网膜下腔出血管理进展:系统综述

Updates in the Management of Cerebral Infarctions and Subarachnoid Hemorrhage Secondary to Intracranial Arterial Dissection: A Systematic Review.
PubMed 文献 · World Neurosurg · 2018-09-27

本系统综述依据PRISMA指南检索MEDLINE(PubMed)与Cochrane Library,纳入82项仅涉及颅内血管夹层人类患者的研究,评估颅内动脉夹层(IAD)的管理与治疗选择。IAD最常见并发症为脑梗死和蛛网膜下腔出血,缺血患者以抗血小板治疗为主,出血患者常适合血管内技术治疗。作者建议对缺血性IAD患者处方抗血小板治疗,对出血性患者考虑血管内治疗,但鉴于研究方法与报告结局的异质性,需进一步研究。

要点

  • IAD最常见并发症为脑梗死和蛛网膜下腔出血,可据此分为缺血型与出血型。
  • 缺血型IAD患者以抗血小板治疗为主。
  • 出血型IAD患者常适合血管内技术治疗。

核心结论

  • 作者建议临床医生对表现为缺血的IAD患者处方抗血小板治疗,对表现为出血的患者考虑血管内治疗。
  • 鉴于所纳入研究方法与报告结局的异质性,需进一步研究。

研究设计与样本

  • 系统综述,依据PRISMA指南检索MEDLINE(PubMed)与Cochrane Library,纳入研究限于颅内血管夹层的人类患者,共纳入82项研究。

主要发现

  • IAD最常见并发症为脑梗死和蛛网膜下腔出血,患者可相应分为缺血型与出血型。
  • 缺血型患者以抗血小板治疗为主,出血型患者常适合血管内技术治疗。

临床怎么用

  • 作者建议对表现为缺血的IAD患者处方抗血小板治疗。
  • 作者建议对表现为出血的IAD患者考虑血管内治疗。

局限性

  • 原文指出所纳入研究的方法与报告结局存在异质性,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intracranial arterial dissection (IAD) is a rare cerebrovascular disease that is likely underdiagnosed because of the inherent difficulty of visualizing the subtle radiographic signs of the pathologic small intracranial arteries. No widespread consensus exists on the treatment of IAD, and thus it is often managed empirically because of the absence of major randomized controlled trials. In this study, we conducted a systematic review to evaluate the management and treatment options for IAD. METHODS: We performed a systematic review in accordance with the PRISMA guidelines using the following databases: MEDLINE (PubMed) and Cochrane Library. Included studies were limited to human patients with dissections in intracranial vessels only. RESULTS: A total of 82 studies were included in this systematic review. The most common complications of IAD were cerebral infarction and subarachnoid hemorrhage, and thus, patients with IAD can be subdivided into those presenting with either ischemia or hemorrhage, respectively. Those with ischemia were predominantly managed with antiplatelet therapy, whereas patients presenting with hemorrhage often were amenable to treatment with endovascular techniques. CONCLUSIONS: Given these findings, clinicians should prescribe antiplatelet therapy for patients with IAD presenting with ischemia and consider endovascular treatment for those presenting with hemorrhage. However, further investigation is required given the heterogeneity of methods and reporting outcomes in the investigated studies.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Al-Mufti F, Kamal N, Damodara N, et al. Updates in the Management of Cerebral Infarctions and Subarachnoid Hemorrhage Secondary to Intracranial Arterial Dissection: A Systematic Review. World Neurosurg. 2018. PMID: 30268550. doi:10.1016/j.wneu.2018.09.153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。